Clinical Trial Update: Efficacy and Safety Study of a IMSS Developed Phytopharmaceutical for the Treatment of Anxiety. [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating an IMSS-developed phytopharmaceutical for generalized anxiety disorder; efficacy and safety data not yet available.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Generalized Anxiety Disorder

Drugs mentioned

• IMSS Developed Phytopharmaceutical

Snippet

Sponsor: Coordinación de Investigación en Salud, Mexico | Conditions: Generalized Anxiety Disorder | Phase 2 | Status: UNKNOWN